SCHEMBL21859245

SCHEMBL21859245

CNCC/C=C1/c2ccccc2CCc2cc(Br)ccc21

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.76
CYP3A4 P08684 5/20 0.76
SLC6A2 P23975 4/20 0.76
CYP1A2 P05177 4/20 0.76
CYP2D6 P10635 3/20 0.76
HTR2B P41595 3/20 0.76
RET P07949 3/20 0.76
HRH1 P35367 3/20 0.76
KCNH2 Q12809 3/20 0.76
ADRB2 P07550 2/20 0.76
CHRM2 P08172 2/20 0.76
CHRM4 P08173 2/20 0.76
ADRB1 P08588 2/20 0.76
HTR1A P08908 2/20 0.76
CHRM5 P08912 2/20 0.76
ADRA2A P08913 2/20 0.76
CHRM1 P11229 2/20 0.76
DRD2 P14416 2/20 0.76
ADRA2B P18089 2/20 0.76
ADRA2C P18825 2/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nortriptyline SCHEMBL7092935 0.87 LMNA (0.94) LMNACYP3A4SLC6A2CYP1A2CYP2D6
Nortriptyline SCHEMBL34527 0.87 SLC6A2 (1.00) LMNACYP3A4SLC6A2CYP1A2CYP2D6
Nortriptyline SCHEMBL29362430 0.87 SLC6A2 (1.00) LMNACYP3A4SLC6A2CYP1A2CYP2D6
Nortriptyline SCHEMBL1286980 0.87 SLC6A2 (1.00) LMNACYP3A4SLC6A2CYP1A2CYP2D6
Nortriptyline SCHEMBL29751879 0.86 CYP3A4 (1.00) LMNACYP3A4SLC6A2CYP1A2CYP2D6
Nortriptyline SCHEMBL41329 0.86 CYP3A4 (1.00) LMNACYP3A4SLC6A2CYP1A2CYP2D6
Nortriptyline SCHEMBL7158809 0.86 SLC6A2 (0.97) LMNACYP3A4SLC6A2CYP1A2CYP2D6
SCHEMBL21859431 0.85 LMNA (0.78) LMNACYP3A4SLC6A2CYP1A2CYP2D6
SCHEMBL22147029 0.85 LMNA (0.78) LMNACYP3A4SLC6A2CYP1A2CYP2D6
Nortriptyline SCHEMBL2244623 0.84 SLC6A2 (0.94) LMNACYP3A4SLC6A2CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020063999-A1 MONO HALOGEN OR METHYL-SUBSTITUTED 5-HT2B ANTAGONISTS WITH INCREASED ACTIVITY NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2020-04-02 WO disclosed